Development Level

Tbio 41 | 11,445
Tdark 20 | 6,588

IMPC Phenotype

abnormal behavior 2 | 298
decreased body weight 2 | 161
decreased hemoglobin content 2 | 68
trunk curl 2 | 16
abnormal bone mineralization 1 | 38
abnormal bone structure 1 | 187
abnormal kidney morphology 1 | 65
abnormal spinal cord morpholog... 1 | 9
abnormal vocalization 1 | 21
decreased bone mineral content 1 | 151
decreased bone mineral density 1 | 126
decreased caudal vertebrae num... 1 | 53
decreased circulating LDL chol... 1 | 38
decreased circulating free fat... 1 | 31
decreased circulating glucose ... 1 | 126
decreased lean body mass 1 | 135
decreased lumbar vertebrae num... 1 | 2
decreased mean corpuscular hem... 1 | 50
decreased mean corpuscular hem... 1 | 31
decreased sacral vertebrae num... 1 | 1
decreased total body fat amoun... 1 | 207
decreased vertical activity 1 | 208
increased circulating alkaline... 1 | 122
increased circulating calcium ... 1 | 34
increased circulating creatini... 1 | 38
increased circulating sodium l... 1 | 71
increased circulating triglyce... 1 | 42
increased fasted circulating g... 1 | 76
increased lean body mass 1 | 172
increased lumbar vertebrae num... 1 | 1
increased sacral vertebrae num... 1 | 1
increased startle reflex 1 | 112
increased total body fat amoun... 1 | 134
polycystic kidney 1 | 15
preweaning lethality, incomple... 1 | 499
shortened RR interval 1 | 17
thrombocytopenia 1 | 56
tremors 1 | 39

Disease

Carcinoma 25 | 11,493
lung adenocarcinoma 23 | 2,716
Breast cancer 22 | 3,578
psoriasis 21 | 6,694
lung cancer 19 | 4,740
ovarian cancer 17 | 8,520
invasive ductal carcinoma 15 | 2,951
breast carcinoma 14 | 1,638
osteosarcoma 14 | 7,950
atypical teratoid / rhabdoid tumor 12 | 5,112
malignant mesothelioma 12 | 3,232
non-small cell lung cancer 12 | 2,890
ductal carcinoma in situ 11 | 1,745
glioblastoma 11 | 5,792
medulloblastoma, large-cell 10 | 6,241
non-small cell lung carcinoma 10 | 317
pancreatic cancer 10 | 2,398
Cancer 9 | 2,499
intraductal papillary-mucinous carcinoma (IPMC) 9 | 2,989
colon cancer 8 | 1,478
cystic fibrosis 8 | 1,696
group 3 medulloblastoma 8 | 4,104
hepatocellular carcinoma 8 | 547
intraductal papillary-mucinous neoplasm (IPMN) 8 | 3,291
Multiple myeloma 7 | 1,332
cutaneous lupus erythematosus 7 | 1,057
gastric cancer 7 | 459
diabetes mellitus 6 | 1,728
lung carcinoma 6 | 2,843
pancreatic carcinoma 6 | 562
Endometriosis 5 | 540
Schizophrenia 5 | 1,160
acute myeloid leukemia 5 | 783
inflammatory breast cancer 5 | 286
pituitary cancer 5 | 1,972
primitive neuroectodermal tumor 5 | 3,035
Breast Neoplasms 4 | 445
Mammary Neoplasms 4 | 425
ependymoma 4 | 4,679
group 4 medulloblastoma 4 | 1,855
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,955
spina bifida 4 | 1,074
subependymal giant cell astrocytoma 4 | 2,287
tuberculosis 4 | 2,010
Atopic dermatitis 3 | 952
Cleft Palate 3 | 271
Connective tissue disease 3 | 62
Intellectual disability 3 | 1,016
Lupus erythematosus 3 | 57
Male infertility 3 | 206
Multiple Sclerosis 3 | 540
nasopharyngeal carcinoma 3 | 1,058
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,962
pediatric high grade glioma 3 | 1,064
sonic hedgehog group medulloblastoma 3 | 467
ulcerative colitis 3 | 1,819
Adenocarcinoma of lung 2 | 142
Adenoid Cystic Carcinoma 2 | 99
Ankylosing spondylitis 2 | 140
Astrocytoma, Pilocytic 2 | 3,081
Atypical teratoid rhabdoid tumor 2 | 6
Carcinoma, Adenoid Cystic 2 | 99
Disease Models, Animal 2 | 155
Down syndrome 2 | 499
Immune system cancer 2 | 140
Influenza 2 | 142
Lymphoid leukemia 2 | 160
Measles 2 | 22
Paratyphoid fever 2 | 10
Pick disease 2 | 1,894
Primary ciliary dyskinesia 2 | 76
Retinitis pigmentosa 11 2 | 59
Retinitis pigmentosa 20 2 | 5
Rheumatoid arthritis 2 | 1,191
Thyroiditis 2 | 29
active ulcerative colitis 2 | 764
acute quadriplegic myopathy 2 | 1,158
adrenocortical carcinoma 2 | 1,428
adult high grade glioma 2 | 3,801
astrocytic glioma 2 | 2,597
astrocytoma 2 | 1,146
interstitial cystitis 2 | 2,312
juvenile dermatomyositis 2 | 1,187
non primary Sjogren syndrome sicca 2 | 891
posterior fossa group A ependymoma 2 | 468
tuberculosis and treatment for 6 months 2 | 409
DOID:2627 1 | 94
Essential Hypertension 1 | 94
Fanconi anemia 1 | 56
Ganglioglioma 1 | 13
Gastric antral vascular ectasia 1 | 10
Malaria 1 | 160
Parkinson Disease 1 | 64
Pilocytic astrocytoma 1 | 56
Waldenstrons macroglobulinemia 1 | 765
X-linked cerebral adrenoleukodystrophy 1 | 116
active Crohn's disease 1 | 922
autosomal dominant Emery-Dreifuss muscular dystrophy 1 | 510
hereditary spastic paraplegia 1 | 318
progressive supranuclear palsy 1 | 676

Tissue

Endocrine System 58 | 18,159
Female tissues 56 | 17,400
Digestive Tract 54 | 17,369
Male tissues 54 | 17,142
Skin and soft tissues 54 | 17,230
Blood and immune system 53 | 16,909
Nervous System 53 | 16,725
Liver and Pancreas 52 | 16,750
Respiratory system 51 | 16,393
Urinary Tract 51 | 16,678
Cardiovascular System 50 | 15,192

Target Family

Non-IDG 57 | 12,091
Transcription Factor 4 | 1,400

PANTHER Protein Class (2)

histone 61 | 61
protein kinase 257 | 257
serine protease 175 | 175
ribosomal protein 152 | 152
cysteine protease 142 | 142
metalloprotease 135 | 135
mRNA processing factor 122 | 122
calmodulin 113 | 113
chromatin/chromatin-binding pr... 106 | 106
serine protease inhibitor 94 | 94
non-motor actin binding protei... 90 | 90
homeodomain transcription fact... 88 | 88
small GTPase 81 | 81
guanyl-nucleotide exchange fac... 77 | 77
translation factor 76 | 76
ligand-gated ion channel 69 | 69
microtubule binding motor prot... 62 | 62
non-motor microtubule binding ... 57 | 57
kinase activator 55 | 55
chemokine 48 | 48
DNA-directed RNA polymerase 46 | 46
ribonucleoprotein 44 | 44
heterotrimeric G-protein 43 | 43
protein phosphatase 41 | 41
nucleotide kinase 37 | 37
RNA helicase 35 | 35
phosphatase inhibitor 34 | 34
nucleotide phosphatase 33 | 33
actin and actin related protei... 31 | 31
kinase inhibitor 31 | 31
phospholipase 30 | 30
ATP synthase 28 | 28
DNA helicase 28 | 28
actin binding motor protein 27 | 27
C2H2 zinc finger transcription... 25 | 25
calcium channel 23 | 23
DNA-directed DNA polymerase 22 | 22
endoribonuclease 22 | 22
tubulin 22 | 22
aspartic protease 21 | 21
exoribonuclease 21 | 21
type I cytokine receptor 20 | 20
anion channel 19 | 19
carbohydrate kinase 17 | 17
endodeoxyribonuclease 15 | 15
intermediate filament binding ... 15 | 15
neuropeptide 15 | 15
potassium channel 15 | 15
DNA methyltransferase 12 | 12
type II cytokine receptor 12 | 12
RNA methyltransferase 11 | 11
damaged DNA-binding protein 11 | 11
tumor necrosis factor family m... 11 | 11
sodium channel 9 | 9
neurotrophic factor 8 | 8
replication origin binding pro... 8 | 8
winged helix/forkhead transcri... 8 | 8
carbohydrate phosphatase 6 | 6
amino acid kinase 5 | 5
guanylate cyclase 5 | 5
DNA topoisomerase 4 | 4
interleukin superfamily 4 | 4
CREB-related transcription fac... 3 | 3
C4 zinc finger nuclear recepto... 2 | 2
DNA photolyase 2 | 2
Lambda repressor-like transcri... 2 | 2
cysteine protease inhibitor 2 | 2
tumor necrosis factor receptor 2 | 2
DNA glycosylase 1 | 1
DNA polymerase processivity fa... 1 | 1
centromere DNA-binding protein 1 | 1
exodeoxyribonuclease 1 | 1
phosphatase activator 1 | 1
primase 1 | 1
reverse transcriptase 1 | 1

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Histone H2A type 1-A HIST1H2AA Tbio Non-IDG -0.84480 8.19 69
Histone H2B type 1-N HIST1H2BN Tbio Non-IDG -1.51422 30.2 60
Histone H2B type 1-L HIST1H2BL Tdark Non-IDG 0.35 0.40 48
Metastasis-associated protein MTA3 MTA3 Tbio Transcription Factor -1.36174 24.5 204
Histone H1.2 HIST1H1C Tbio Non-IDG -2.01718 95.3 142
Histone H1.3 HIST1H1D Tbio Non-IDG -1.83212 63.8 66
Histone H1.5 HIST1H1B Tbio Non-IDG -2.13224 134.1 103
Histone H2A type 1-B/E HIST1H2AB Tbio Non-IDG -1.27041 18.5 133
Putative histone H2B type 2-C HIST2H2BC Tdark Non-IDG 0.00000 0
Histone H2A.J H2AFJ Tdark Non-IDG -0.00172 0.83 99